Figure 6 | Scientific Reports

Figure 6

From: Efficacy of eribulin for metastatic breast cancer based on localization of specific secondary metastases: a post hoc analysis

Figure 6

Summary of tumor response as assessed by investigators per RECIST version 1.0, by site of lesions at baseline (pooled population). The overall response rates were similar across the pooled population regardless of location of metastases at baseline. Control includes TPC and capecitabine; odds ratio (95% CI) was calculated using Cochran-Mantel-Haenszel test, stratified by study. CI, confidence interval; RECIST, Response Evaluation Criteria In Solid Tumors; TPC, treatment of physician’s choice.

Back to article page